class name | count |
---|---|
rosids | 250 |
asterids | 2 |
eudicotyledons | 1 |
class name | count |
---|---|
Fabaceae | 103 |
Moraceae | 67 |
Clusiaceae | 49 |
Calophyllaceae | 16 |
Hypericaceae | 11 |
Euphorbiaceae | 2 |
Lamiaceae | 2 |
Combretaceae | 2 |
Berberidaceae | 1 |
br08003 Category | # of metabolite |
---|---|
Isoflavones | 1 |
Xanthenes | 1 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Isoflavones | C10519 | C00002562 |
Xanthenes | C10076 | C00002961 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00001070
![]() |
Morusin
/ Mulberrochromene / 2-(2,4-Dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL464006
|
C057451
|
16 / 17 / 10 |
![]() |
|
C00002555
![]() |
Osajin
|
CHEMBL238188
|
36 / 50 / 70 |
![]() |
||
C00002562
![]() |
Pomiferin
|
CHEMBL393136
|
37 / 43 / 61 |
![]() |
||
C00002961
![]() |
Macluraxanthone
/ 3-Hydroxyblancoxanthone |
CHEMBL478960
|
5 / 11 / 11 |
![]() |
||
C00004021
![]() |
Brosimone I
/ (E)-(+)-3,8,10-Trihydroxy-9-(3-methyl-1-butenyl)-6-(2-methyl-1-propenyl)-6H,7H-[1]benzopyrano[4,3-b][1]benzopyran-7-one |
![]() |
||||
C00004029
![]() |
Cyclomorusin
/ Cyclomulberrochromene / 6,11-Dihydroxy-3,3-dimethyl-8-(2-methyl-1-propenyl)-3H,7H,8H-bis[1]benzopyrano[4,3-b:6',5'-e]pyran-7-one |
CHEMBL1770313
|
1 / 0 / 0 |
![]() |
||
C00004038
![]() |
Brosimone G
|
![]() |
||||
C00004044
![]() |
Fulvinervin B
/ (E)-5-Hydroxy-8,8-dimethyl-6-(3-methyl-1,3-butadienyl)-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one / 5-Hydroxy-8,8-dimethyl-6-[(1E)-3-methyl-1,3-butadienyl]-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
![]() |
||||
C00004045
![]() |
Fulvinervin C
/ (E)-5-Hydroxy-6-(3-hydroxy-3-methyl-1-butenyl)-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one / 5-Hydroxy-6-[(1E)-3-hydroxy-3-methyl-1-butenyl]-8,8-dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
![]() |
||||
C00004055
![]() |
Cycloartomunin
/ 6,12-Dihydroxy-11-methoxy-3,3-dimethyl-8-(2-methyl-1-propenyl)-3H,7H,8H-bis[1]benzopyrano[4,3-b:6',5'-e]pyran-7-one |
![]() |
||||
C00004056
![]() |
Kuwanon B
|
![]() |
||||
C00004057
![]() |
Kuwanon A
|
CHEMBL1770312
|
1 / 0 / 0 |
![]() |
||
C00004059
![]() |
Morusinol
/ Oxydihydromorusin / 2-(2,4-Dihydroxyphenyl)-5-hydroxy-3-(3-hydroxy-3-methylbutyl)-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL1719948
|
10 / 5 / 2 |
![]() |
||
C00004063
![]() |
Desmodol
|
![]() |
||||
C00004066
![]() |
Artobilichromene
|
![]() |
||||
C00004092
![]() |
Kanzonol E
/ 2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)-7-hydroxy-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
![]() |
||||
C00004093
![]() |
Laxifolin
/ 5-Hydroxy-2-(4-hydroxyphenyl)-8,8-dimethyl-6-(3-methyl-2-butenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
![]() |
||||
C00004094
![]() |
Isolaxifolin
/ 5-Hydroxy-8-(4-hydroxyphenyl)-2,2-dimethyl-10-(3-methyl-2-butenyl)-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one |
![]() |
||||
C00004098
![]() |
Isocyclomorusin
/ (+)-3,8-Dihydroxy-11,11-dimethyl-6-(2-methyl-1-propenyl)-6H,7H,11H-bis[1]benzopyrano[4,3-b:6',7'-e]pyran-7-one |
CHEMBL230558
|
![]() |
|||
C00004101
![]() |
Cycloartocarpin A
|
CHEMBL463093
|
![]() |
|||
C00004105
![]() |
KB-2
/ 5,2',4',5'-Tetrahydroxy-3-(3-hydroxy-3-methylbutyl)-6'',6''-dimethylpyrano[2'',3'':7,8]flavone |
![]() |
||||
C00004106
![]() |
KB 3
/ Artonin E / 5-Hydroxy-8,8-dimethyl-3-(3-methyl-2-butenyl)-2-(2,4,5-trihydroxyphenyl)-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one |
CHEMBL463106
|
C066727
|
![]() |
||
C00005075
![]() |
Sericetin
|
CHEMBL1495541
|
2 / 0 / 1 |
![]() |
||
C00005083
![]() |
Macaflavone I
|
![]() |
||||
C00005084
![]() |
Macaflavone II
|
![]() |
||||
C00005086
![]() |
Broussoflavonol A
/ 8-(3,4-Dihydroxyphenyl)-5-hydroxy-7-methoxy-2,2-dimethyl-10-(3-methyl-2-butenyl)-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one |
![]() |
||||
C00009447
![]() |
Munetone
|
CHEMBL463492
|
![]() |
|||
C00009448
![]() |
Cajaisoflavone
|
![]() |
||||
C00009449
![]() |
Mundulone
|
CHEMBL465339
|
11 / 19 / 44 |
![]() |
||
C00009513
![]() |
Chandalone
|
![]() |
||||
C00009514
![]() |
Scandenone
/ Warangalone |
CHEMBL458134
|
C105205
|
![]() |
||
C00009518
![]() |
Nallanin
/ Scandinone |
![]() |
||||
C00009519
![]() |
Isoauriculatin
|
![]() |
||||
C00009520
![]() |
Isoauriculasin
|
![]() |
||||
C00009521
![]() |
Auriculatin
|
![]() |
||||
C00009522
![]() |
Auriculasin
/ Cudraisoflavone A |
CHEMBL459129
|
![]() |
|||
C00009525
![]() |
Auriculin
/ Auriculatin 4'-methyl ether |
![]() |
||||
C00009532
![]() |
Millettin
|
![]() |
||||
C00009836
![]() |
4'-O-Prenylalpinumisoflavone
|
CHEMBL1970103
|
![]() |
|||
C00009915
![]() |
Isochandalone
/ 5,7-Dihydroxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
CHEMBL460441
|
![]() |
|||
C00009919
![]() |
Angustone B
/ 5,7,2'-Trihydroxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
![]() |
||||
C00009923
![]() |
Gancaonin H
/ 5,7,3'-Trihydroxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':4',5']isoflavone |
![]() |
||||
C00009929
![]() |
Angustone C
/ 5,2',4'-Trihydroxy-3'-prenyl-6'',6''-dimethylpyrano[2'',3'':7,6]isoflavone |
![]() |
||||
C00009930
![]() |
Lupinisoflavone L
|
![]() |
||||
C00009934
![]() |
Lupinisoflavone K
|
![]() |
||||
C00009935
![]() |
Ulexone A
/ 5,7-Dihydroxy-8-prenyl-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
CHEMBL461062
|
![]() |
|||
C00009937
![]() |
Ulexone B
|
![]() |
||||
C00009938
![]() |
Ulexone D
|
![]() |
||||
C00009939
![]() |
Ulexone C
|
![]() |
||||
C00009943
![]() |
Euchrenone b8
|
![]() |
||||
C00009944
![]() |
Euchrenone b6
|
![]() |
||||
C00009947
![]() |
Euchrenone b3
/ 5-Hydroxy-2'-methoxy-4',5'-methylenedioxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':7,8]isoflavone |
![]() |
||||
C00009948
![]() |
Euchrenone b9
|
![]() |
||||
C00009949
![]() |
Euchrenone b7
|
![]() |
||||
C00011150
![]() |
Ulexin C
|
CHEMBL517608
|
![]() |
|||
C00011151
![]() |
Ulexin D
|
CHEMBL517314
|
![]() |
|||
C00013393
![]() |
Muxiangrin III
/ Muxiangrine III / 2-[3,4-Dihydroxy-5-(3-methyl-2-butenyl)phenyl]-5-hydroxy-7-methoxy-6,8-dimethyl-4H-1-benzopyran-4-one |
![]() |
||||
C00013395
![]() |
Muxiangrin I
/ Muxiangrine I / 5-Hydroxy-2-(8-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-7-methoxy-6,8-dimethyl-4H-1-benzopyran-4-one |
![]() |
||||
C00013442
![]() |
Australone A
/ 2H,(-)-8-(2,4-Dihydroxyphenyl)-5-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-6H-benzo[1,2-b:5,4-b']dipyran-6-one |
![]() |
||||
C00013456
![]() |
Yinyanghuo A
/ (-)-5,7-Dihydroxy-2-[8-(2-hydroxy-3-methyl-3-butenyl)-2,2-dimethyl-2H-1-benzopyran-6-yl]-4H-1-benzopyran-4-one |
CHEMBL462969
|
![]() |
|||
C00013459
![]() |
Morusignin L
|
![]() |
||||
C00013485
![]() |
Cycloartobiloxanthone
/ 5a,6-Dihydro-1,3,8-trihydroxy-5,5,11,11-tetramethyl-5H,7H,11H-benzofuro[3,4-bc]pyrano[3,2-h]xanthen-7-one |
CHEMBL516519
|
2 / 0 / 0 |
![]() |
||
C00013488
![]() |
Cycloartomunoxanthone
/ 5a,6-Dihydro-1,8-dihydroxy-3-methoxy-5,5,11,11-tetramethyl-5H,7H,11H-benzofuro[3,4-bc]pyrano[3,2-h]xanthen-7-one |
![]() |
||||
C00013499
![]() |
Artocommunol CA
/ (+)-6-Hydroxy-11-methoxy-3,3-dimethyl-8-(2-methyl-1-propenyl)-3H,7H,8H-bis[1]benzopyrano[4,3-b:6',5'-e]pyran-7-one |
![]() |
||||
C00013536
![]() |
Broussonol B
/ 8,9-Dihydro-3,5-dihydroxy-2-(8-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-8,9,9-trimethyl-4H-furo[2,3-h]-1-benzopyran-4-one |
CHEMBL457086
|
![]() |
|||
C00013538
![]() |
Broussonol A
/ 8-(1,1-Dimethyl-2-propenyl)-3,5,7-trihydroxy-2-(8-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-4H-1-benzopyran-4-one |
CHEMBL457085
|
![]() |
|||
C00018940
![]() |
Lespedezol A3
/ 3,8-Dihydroxy-6'-methyl-6'-(4-methyl-3-pentenyl)pyrano[2',3':9,10]pterocarpene |
![]() |
||||
C00019079
![]() |
Scanderone
/ 4',5-Dihydroxy-3'-prenyl-2'',2''-dimethylchromeno[7,8:6'',5'']isoflavone |
![]() |
||||
C00019080
![]() |
Ulexin B
|
![]() |
||||
C00019084
![]() |
Kraussianone 1
/ 5,2'-Dihydroxy-(2'',3'':7,6),(2''',3''':4',3')-bis(6,6-dimethylpyrano)isoflavone |
![]() |
||||
C00019085
![]() |
Kraussianone 2
/ 5,7,2'-Trihydroxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':4',5']isoflavone |
![]() |
||||
C00019086
![]() |
Kraussianone 3
/ 5,7,2'-Trihydroxy-6-(3-hydroxy-3-methyl-3-butyl)-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
![]() |
||||
C00019097
![]() |
Kraussianone 6
/ 5,2',5''-Trihydroxy-4'',5''-dihydro-(2'',3'':7,6),(2''',3''':4',3')-bis(6,6-dimethylpyrano)isoflavone |
![]() |
||||
C00019098
![]() |
Kraussianone 7
/ 5,7,2'-Trihydroxy-6-(2-hydroxy-3-methyl-3-butenyl)-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
![]() |
||||
C00019156
![]() |
5-O-Methyl-4'-O-(3-methylbut-2-enyl)alpinumisoflavone
|
![]() |
||||
C00019168
![]() |
Formosanatin D
|
![]() |
||||
C00019170
![]() |
Euchretin G
|
![]() |
||||
C00019247
![]() |
Artoindonesianin Y
/ 3',5'-Dihydroxy-2',6'-diprenyl-6'',6''-dimethylpyrano[2'',3'':6,7]-2-arylbenzofuran |
![]() |
||||
C00019317
![]() |
2-(1-Hydroxy-1-methylethyl)-3-hydroxy-2,3-dihydrofuranoalpinumisoflavone
|
![]() |
||||
C00019370
![]() |
Ulexin A
/ 5,7-Dihydroxy-6-(2-hydroxy-3-methyl-3-butenyl)-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
![]() |
||||
C00019414
![]() |
Euchretin H
|
![]() |
||||
C00019466
![]() |
Kanzonol V
/ 5,4'-Dihydroxy-6-prenyl-6'',6''-dimethylpyrano[2'',3'':2',3']-2-arylbenzofuran |
![]() |
||||
C00019474
![]() |
Kanzonol T
/ 5,7,2'-Trihydroxy-6-(3-hydroxy-3-methylbutyl)-6'',6''-dimethylpyrano[2'',3'':4',3']isoflavone |
![]() |
||||
C00019502
![]() |
Isoerythrin-A 4'-(3-methylbut-2-enyl)ether
|
![]() |
||||
C00019514
![]() |
Erysenegalensein L
/ 5,2',4'-Trihydroxy-8-(2'''-hydroxy-3'''-methyl-3'''-butenyl)-6'',6''-dimethylpyrano[2'',3'':7,6]isoflavone |
![]() |
||||
C00019538
![]() |
Ormosidin
/ 7,4'-Dihydroxy-6'',6''-dimethylpyrano[2'',3'':5,6]-8-(3-methyl-1,3-butadienyl)isoflavone |
![]() |
||||
C00019540
![]() |
Eturunagarone
/ 5,4'-Dihydroxy-8-(3-methoxy-3-methylbutyl)-6'',6''-dimethylpyrano[2'',3'':7,6]-isoflavone |
![]() |
||||
C00019623
![]() |
Glyasperin N
/ 5,7,4'-Trihydroxy-8-prenyl-6'',6''-dimethylpyrano[2'',3'':2',3']isoflavone |
![]() |
||||
C00019626
![]() |
7,6]isoflavone
/ Erysenegalensein F / 5,2',4'-Trihydroxy-8-(2,3-epoxy-3-methylbutyl)-6'',6''-dimethylpyrano[2'',3'' |
![]() |
||||
C00019669
![]() |
2'-O-Methylisoauriculatin
|
![]() |
||||
C00020492
![]() |
Flemiphilippinin C
|
C070776
|
![]() |
|||
C00024193
![]() |
Gerontoxanthone A
|
CHEMBL517514
|
7 / 10 / 6 |
![]() |
||
C00024194
![]() |
Gerontoxanthone B
|
CHEMBL478938
|
![]() |
|||
C00029567
![]() |
5'-Hydroxycudraflavone A
|
![]() |
||||
C00029729
![]() |
Artoindonesianin D
|
![]() |
||||
C00030035
![]() |
Cudraflavone A
|
CHEMBL230558
|
![]() |
|||
C00030107
![]() |
Demethylcalabaxanthone
|
CHEMBL564653
|
![]() |
|||
C00030356
![]() |
Garcinone B
|
CHEMBL560332
|
![]() |
|||
C00030897
![]() |
Osajin 4'-methyl ether
|
![]() |
||||
C00031562
![]() |
Acetyl blancoxanthone
|
![]() |
||||
C00032105
![]() |
Padiaxanthone
/ Brasilixanthone B |
![]() |
||||
C00032355
![]() |
Thwaitesixanthone
|
CHEMBL2006383
|
![]() |
|||
C00032505
![]() |
Warangalone 4'-methyl ether
|
![]() |
||||
C00032517
![]() |
Xanthone V1
|
![]() |
||||
C00034827
![]() |
Cowaxanthone D
/ Dulcisxanthone F |
![]() |
||||
C00034842
![]() |
Formoxanthone A
|
CHEMBL1254112
|
![]() |
|||
C00034875
![]() |
Morusignin J
|
CHEMBL2147812
|
![]() |
|||
C00034889
![]() |
Rheediaxanthone A
|
![]() |
||||
C00034916
![]() |
Vogelin I
/ (+)-Vogelin I |
![]() |
||||
C00035249
![]() |
Bangangxanthone A
|
![]() |
||||
C00035818
![]() |
Caloxanthone A
|
![]() |
||||
C00035841
![]() |
Inoxanthone
|
![]() |
||||
C00036131
![]() |
Latisxanthone D
|
CHEMBL469412
|
![]() |
|||
C00036177
![]() |
Nigrolineaxanthone B
|
![]() |
||||
C00036182
![]() |
Nigrolineaxanthone G
|
![]() |
||||
C00036184
![]() |
Nigrolineaxanthone I
|
![]() |
||||
C00036836
![]() |
Brasilixanthone A
|
![]() |
||||
C00036862
![]() |
Caloxanthone D
|
![]() |
||||
C00036963
![]() |
Cudraxanthone B
|
![]() |
||||
C00036966
![]() |
Cudraxanthone K
|
![]() |
||||
C00037370
![]() |
Kayeaxanthone
|
![]() |
||||
C00037472
![]() |
Manglexanthone
|
![]() |
||||
C00037494
![]() |
Merguenone
|
![]() |
||||
C00037602
![]() |
Paxanthone B
|
![]() |
||||
C00037708
![]() |
Pyranojacareubin
|
![]() |
||||
C00037861
![]() |
Subelliptenone H
|
![]() |
||||
C00037919
![]() |
Tovopyrifolin A
|
![]() |
||||
C00039430
![]() |
Isocudraxanthone K
|
CHEMBL390040
|
![]() |
|||
C00040462
![]() |
Termicalcicolanone A
|
CHEMBL224141
|
![]() |
|||
C00040463
![]() |
Termicalcicolanone B
|
![]() |
||||
C00040543
![]() |
Trapezifolixanthone
|
C401852
|
![]() |
|||
C00040963
![]() |
Garciniaxanthone B
|
CHEMBL481243
|
![]() |
|||
C00041222
![]() |
(-)-Cudraflavone A
|
CHEMBL230558
|
![]() |
|||
C00041223
![]() |
(-)-Cycloartocarpin
|
CHEMBL525350
|
![]() |
|||
C00042227
![]() |
Ananixanthone
|
CHEMBL460547
|
![]() |
|||
C00042432
![]() |
Cycloartelastoxanthendiol
/ (-)-Cycloartelastoxanthendiol |
CHEMBL464517
|
![]() |
|||
C00042749
![]() |
Morusignin I
|
![]() |
||||
C00042772
![]() |
Nigrolineaxanthone V
|
![]() |
||||
C00044541
![]() |
Artocommunol CE
/ (+)-Artocommunol CE |
![]() |
||||
C00044572
![]() |
Brasixanthone A
|
![]() |
||||
C00044573
![]() |
Brasixanthone B
|
![]() |
||||
C00044574
![]() |
Brasixanthone C
|
![]() |
||||
C00044575
![]() |
Brasixanthone D
|
![]() |
||||
C00044576
![]() |
Brasixanthone E
|
![]() |
||||
C00044782
![]() |
Globulixanthone B
/ (+)-Globulixanthone B |
CHEMBL464752
|
![]() |
|||
C00044959
![]() |
Nigrolineaxanthone K
|
CHEMBL462457
|
![]() |
|||
C00044961
![]() |
Nigrolineaxanthone M
|
CHEMBL518394
|
![]() |
|||
C00045814
![]() |
Cudraxanthone Q
/ Brasixanthone B |
![]() |
||||
C00045960
![]() |
Garcimangosone B
|
![]() |
||||
C00047431
![]() |
Dehydrolupinifolinol
|
CHEMBL557501
|
![]() |
|||
C00047788
![]() |
Cathafuran C
|
CHEMBL550963
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001070 C00002555 C00002562 C00004059 C00024193 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001070 C00002555 C00002562 C00004059 C00024193 | 2 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001070 C00002555 C00002562 C00004059 C00024193 | 1 / 1 |
O75496 | Geminin | Unclassified protein | C00002555 C00002562 C00004059 C00024193 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002555 C00002562 C00002961 C00009449 | 4 / 1 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001070 C00002555 C00002562 C00004059 | 1 / 1 |
P56817 | Beta-secretase 1 | A1A | C00001070 C00004029 C00004057 C00004059 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001070 C00002555 C00002562 C00004059 | 1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002555 C00002562 C00005075 C00009449 | 0 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001070 C00002555 C00002562 C00004059 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001070 C00002555 C00002562 C00004059 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002555 C00002562 C00009449 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002555 C00002562 C00009449 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00002555 C00002562 C00024193 | 1 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001070 C00002555 C00002562 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002555 C00002562 C00002961 | 4 / 3 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002555 C00002562 C00009449 | 7 / 37 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002555 C00002562 C00009449 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002555 C00002562 C00024193 | 2 / 2 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002555 C00002562 C00024193 | 4 / 2 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002555 C00002562 C00002961 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00002555 C00002562 C00002961 | 2 / 5 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002555 C00005075 C00009449 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001070 C00002562 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00002555 C00009449 | 6 / 4 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00002555 C00002562 | 0 / 3 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001070 C00002562 | 7 / 3 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002562 C00002961 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00001070 C00002562 | 4 / 2 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002555 C00002562 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002555 C00009449 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002555 C00002562 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002562 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001070 | 2 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00013485 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002562 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00009449 | 2 / 2 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00013485 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00002555 | 1 / 1 |
P55210 | Caspase-7 | C14 | C00002562 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002562 | 1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002562 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002562 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00002555 | 1 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00009449 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002555 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001070 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002562 | 0 / 1 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | C00002562 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002555 | 11 / 10 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002555 | 1 / 1 |
O00167 | Eyes absent homolog 2 | Enzyme | C00002555 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002555 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00002555 | 0 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00004059 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001070 | 0 / 3 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00001070 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002555 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002562 | 1 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P18054
P84022 |
#127750 | Dementia, lewy body; dlb |
P37840
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|